From Big Data to the Internet of Things: Can technology help increase uptake of adult immunisations?
We detail below some organisations interested in adult immunisation. We also provide some links to information about vaccine preventable diseases impacting on older people. We will update this list every 3 months. [last updated January 2017]
Médecins Sans Frontières have published a podcast on the experiences of a UK doctor who came across Tetanus in South Sudan.
A systematic review of the relevant literature in English on the cost-effectiveness of immunisation for adults aged 50 years or over in all EU Member States was performed for the SAATI report (see below). Cost-effectiveness studies were found for 13 EU Member States (the UK, Germany, the Netherlands, Sweden, Belgium, France, Italy, Spain, Poland, Denmark, Finland, Slovakia and Czech Republic) and for 4 of the seven key vaccine preventable diseases examined in this report: herpes zoster, seasonal influenza, IPD and pneumococcal pneumonia.
Tetanus is a sporadic and relatively uncommon infection in Europe. The confirmed case rate remains low, mainly because laboratory confirmation is usually not performed for tetanus and diagnosis is based on clinical presentation.
A new study published in Clinical Infectious Diseases argues that it “may no longer be necessary to administer booster vaccinations every 10 years and that the current adult vaccination schedule for tetanus and diphtheria should be revisited”. Researchers found that adults remain protected against tetanus and diphtheria for at least 30 years.